How to Order Ferrlecit 125mg IV
Order Ferrlecit 125 mg (10 mL) diluted in 100 mL of 0.9% sodium chloride, administered as an intravenous infusion over 1 hour per dialysis session. 1
Ordering Specifications
Standard Adult Dosing
- Dose: 125 mg elemental iron (10 mL of Ferrlecit)
- Diluent: 100 mL of 0.9% sodium chloride (normal saline)
- Infusion time: 1 hour
- Frequency: Per dialysis session 1
Alternative Administration Method
If rapid administration is needed, Ferrlecit can be given undiluted as a slow IV injection at a rate of up to 12.5 mg/min (approximately 10 minutes for 125 mg dose) 1. However, the FDA label notes that individual doses exceeding 125 mg may be associated with higher incidence and/or severity of adverse events 1.
Critical Ordering Details
Do not mix Ferrlecit with other medications or add to parenteral nutrition solutions. Administer only in 0.9% saline 1.
Pre-Administration Requirements
Before ordering, ensure:
- ☐ Confirm iron deficiency or iron deficiency anemia diagnosis
- ☐ Review for previous drug allergies, including prior IV iron reactions
- ☐ Check for severe asthma, eczema, or autoimmune conditions (increased hypersensitivity risk) 2
- ☐ Ensure resuscitation equipment and emergency medications (epinephrine) are immediately available 2
- ☐ Verify appropriate IV access with adequate cannula size (e.g., 20G) 2
Monitoring Requirements
- Continuous observation for first 10-15 minutes of infusion 2
- Monitor for hypersensitivity signs: pain at IV site, flushing, chest tightness, back pain, dyspnea, hypotension, urticaria 2
- Reassess cannula site every 5-10 minutes during infusion 2
Important Safety Considerations
Dosing Caution
Research shows that doses of 250 mg or higher are associated with significantly increased adverse reactions (10-30% incidence) in a dose-dependent fashion 3. While some studies report safe administration of 250 mg doses over 1 hour 4, the FDA-approved dose remains 125 mg per session to minimize risk 1.
Contraindications
- Iron overload (do not administer to patients with hemosiderosis) 1
- Active or uncontrolled infection (generally avoided, though evidence suggests no clinically relevant infection risk increase in most populations) 2
Special Populations
- Pediatric dosing: 0.12 mL/kg (1.5 mg/kg elemental iron) diluted in 25 mL 0.9% sodium chloride over 1 hour 1
- Geriatric: Start at low end of dosing range due to decreased organ function 1
- Benzyl alcohol content: Contains 9 mg/mL benzyl alcohol; use caution in neonates 1
Post-Infusion Care
- Flush cannula with 10 mL normal saline before removal 2
- Educate patient on delayed reactions (rash, dizziness, fever, joint pain) 2
- Document dose, batch number, infusion time, and any adverse events 2
Laboratory Monitoring
Do not check iron parameters within 4 weeks of infusion as circulating iron interferes with assays 5. Evaluate CBC and iron parameters (ferritin, TSAT) at 4-8 weeks post-infusion 5. Hemoglobin should increase by 1-2 g/dL within 4-8 weeks of therapy 5.